Colot, Marvin A.

HRN: 21-69-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/26/2023
09/02/2023
IV
500mg
Q8hrs
Intraabdominal Infection
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes